Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice.
Alves CRR, Das S, Krishnan V, Ha LL, Fox LR, Stutzman HE, Shamber CE, Kalailingam P, McCarthy S, Lino Cardenas CL, Fong CE, Imai T, Mitra S, Yun S, Wood RK, Benning FMC, Roh K, Lawton J, Kim N, Silverstein RA, Ferreira da Silva J, de la Cruz D, Richa R, Xie J, Gray-Edwards HL, Malhotra R, Chung DY, Chao LH, Tsai SQ, Maguire CA, Lindsay ME, Kleinstiver BP, Musolino PL.
Alves CRR, et al. Among authors: tsai sq.
Nat Biomed Eng. 2026 May;10(5):952-967. doi: 10.1038/s41551-025-01499-1. Epub 2025 Sep 11.
Nat Biomed Eng. 2026.
PMID: 40935887
Free PMC article.